These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 2728524)

  • 1. Disposition of 3-hydroxyquinidine in patients receiving initial intravenous quinidine gluconate for electrophysiology testing of ventricular tachycardia.
    Ackerman BH; Olsen KM; Kennedy EE; Taylor EH; Chen BH; Jordan D; Ackerman DJ
    DICP; 1989 May; 23(5):375-8. PubMed ID: 2728524
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of disposition values obtained by two assay methods for quinidine gluconate in patients with ventricular tachycardia.
    Ackerman BH; Olsen KM; Kennedy EE; Taylor EH; Chen BH; Jordan D; Ackerman DJ
    Pharmacotherapy; 1989; 9(4):220-5. PubMed ID: 2771807
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prospective comparison of intravenous quinidine and intravenous procainamide in patients undergoing electrophysiologic testing.
    Holzberger PT; Greenberg ML; Paicopolis MC; Ozahowski TP; Ho PC; O'Connor GT
    Am Heart J; 1998 Jul; 136(1):49-56. PubMed ID: 9665218
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Contribution of quinidine metabolites to electrophysiologic responses in human subjects.
    Kavanagh KM; Wyse DG; Mitchell LB; Gilhooly T; Gillis AM; Duff HJ
    Clin Pharmacol Ther; 1989 Sep; 46(3):352-8. PubMed ID: 2776394
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Total and unbound concentrations of quinidine and 3-hydroxyquinidine at steady state.
    Wooding-Scott RA; Visco J; Slaughter RL
    Am Heart J; 1987 Feb; 113(2 Pt 1):302-6. PubMed ID: 3812182
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Greater quinidine-induced QTc interval prolongation in women.
    Benton RE; Sale M; Flockhart DA; Woosley RL
    Clin Pharmacol Ther; 2000 Apr; 67(4):413-8. PubMed ID: 10801251
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Electrophysiologic effects of intravenous 3-hydroxy-dihydroquinidine (LNC-834) in man].
    Weissenburger J; le Heuzey JY; Clementy J; Ertzbischoff O; Coste P; Gutel B; Harley X; Jaillon P; Valty J; Cheymol G
    Arch Mal Coeur Vaiss; 1989 Dec; 82(12):2035-40. PubMed ID: 2515829
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of grapefruit juice on the pharmacokinetics and pharmacodynamics of quinidine in healthy volunteers.
    Min DI; Ku YM; Geraets DR; Lee H
    J Clin Pharmacol; 1996 May; 36(5):469-76. PubMed ID: 8739026
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antiarrhythmic activity of two quinidine metabolites in experimental reperfusion arrhythmia: relative potency and pharmacodynamic interaction with the parent drug.
    Vozeh S; Oti-Amoako K; Uematsu T; Follath F
    J Pharmacol Exp Ther; 1987 Oct; 243(1):297-301. PubMed ID: 3668860
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Itraconazole increases plasma concentrations of quinidine.
    Kaukonen KM; Olkkola KT; Neuvonen PJ
    Clin Pharmacol Ther; 1997 Nov; 62(5):510-7. PubMed ID: 9390107
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fetal supraventricular tachycardia treated with high-dose quinidine: toxicity associated with marked elevation of the metabolite, 3(S)-3-hydroxyquinidine.
    Killeen AA; Bowers LD
    Obstet Gynecol; 1987 Sep; 70(3 Pt 2):445-9. PubMed ID: 3627599
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intravenous quinidine by intermittent bolus for electrophysiologic studies in patients with ventricular tachycardia.
    Torres V; Flowers D; Miura D; Somberg J
    Am Heart J; 1984 Dec; 108(6):1437-42. PubMed ID: 6507239
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The pharmacokinetics and pharmacodynamics of quinidine and 3-hydroxyquinidine.
    Wooding-Scott RA; Smalley J; Visco J; Slaughter RL
    Br J Clin Pharmacol; 1988 Oct; 26(4):415-21. PubMed ID: 3190991
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Accumulation of 3-hydroxyquinidine following chronic quinidine therapy.
    Ackerman BH; Olsen KM; Pappas AA
    DICP; 1991; 25(7-8):867-9. PubMed ID: 1949948
    [No Abstract]   [Full Text] [Related]  

  • 15. Electrocardiographic and electrophysiologic effects of pirmenol in ventricular tachycardia.
    Estes NA; Gold R; Cameron J; Haffajee C; Marshall M; Mack K; Salem DN
    Am J Cardiol; 1987 Jun; 59(16):20H-26H. PubMed ID: 3591711
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modulation of effect of dietary salt on prehepatic first-pass metabolism: effects of beta-blockade and intravenous salt loading.
    Fromm MF; Darbar D; Dell'Orto S; Roden DM
    J Pharmacol Exp Ther; 1999 Jul; 290(1):253-8. PubMed ID: 10381784
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Continuous intravenous quinidine infusion for the treatment of atrial fibrillation or flutter: a case series.
    Allen LaPointe NM; Li P
    Am Heart J; 2000 Jan; 139(1 Pt 1):114-21. PubMed ID: 10618571
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Safety and efficacy of intravenous quinidine.
    Swerdlow CD; Yu JO; Jacobson E; Mann S; Winkle RA; Griffin JC; Ross DL; Mason JW
    Am J Med; 1983 Jul; 75(1):36-42. PubMed ID: 6859083
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Postsurgical ventricular tachycardia in a horse.
    Garber JL; Reef VB; Reimer JM; Evans LH
    J Am Vet Med Assoc; 1992 Oct; 201(7):1038-9. PubMed ID: 1429129
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacodynamics of 3-hydroxyquinidine alone and in combination with quinidine in healthy persons.
    Vozeh S; Bindschedler M; Ha HR; Kaufmann G; Guentert TW; Follath F
    Am J Cardiol; 1987 Mar; 59(6):681-4. PubMed ID: 3825912
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.